Assessing the Impact of Post-COVID Clinics on 6-Month Health Care Utilization for Patients With Long COVID: A Single-Center Experience [0.03%]
评估COVID后门诊对长期新冠患者半年内医疗卫生服务利用率的影响：单中心经验报告
Kirby D Gong,Ali S Afshar,Fred Brown et al.
Kirby D Gong et al.
Objective: To assess the impact of post-COVID clinics by examining the association between their early usage and downstream health care utilization. Patie...
Aleksandra Murawska Baptista,Alicja Kaminska,Marko Gorasevic et al.
Aleksandra Murawska Baptista et al.
Objective: To describe the presenting symptoms, outcomes, and time to diagnosis of ehrlichiosis cases treated at Mayo Clinic, Jacksonville, Florida. Patie...
Differential Sources of Distress in Clinical and Research Trainees: A Focus on Work and Role Relationships [0.03%]
临床和科研受训者压力的差异来源：重视工作和角色关系
Laurence M Boitet,David A Rogers,Katherine L Sweeney et al.
Laurence M Boitet et al.
Objective: To examine the experience of clinical and research trainees within an academic medical center setting to identify and compare factors influencing their wellbeing. ...
A Prospective Randomized Dose-Finding Study of Intrathecal Opioids for Postoperative Analgesia After Minimally Invasive Colorectal Operation [0.03%]
微创结直肠手术术后镇痛硬膜外阿片剂量选择的前瞻性随机研究
Patrice A Vinsard,Josef Pleticha,Emily E Sharpe et al.
Patrice A Vinsard et al.
Objective: To determine the optimal dose of intrathecal morphine and hydromorphone in patients undergoing minimally invasive colorectal operation for postoperative analgesia. ...
A Pilot Study of the Home-Based 12-Lead Electrocardiogram in Clinical Practice [0.03%]
家庭基础的12导联心电图在临床实践中的初步研究
Levi W Disrud,William H Swain,Halley Davison et al.
Levi W Disrud et al.
Telehealth consultation with a physician can be an attractive option for eligible patients. In this pilot study, we evaluate the feasibility and efficiency of an FDA approved 12-lead electrocardiogram (ECG) device, Smeartheart, that can be ...
Follow-up Colorectal Cancer Screening After Negative-Result and Positive-Result Multitarget Stool DNA Tests: A Population-Based Study in Southeast Minnesota [0.03%]
多靶点粪便DNA检测阴性和阳性结果后的结直肠癌筛查：明尼苏达州东南部的人群研究
Alanna M Chamberlain,Derek W Ebner,Gregory D Jenkins et al.
Alanna M Chamberlain et al.
Objective: To provide contemporary data on subsequent screening after negative-result multitarget stool DNA (mt-sDNA) tests and follow-up colonoscopy after positive-result mt-sDNA tests. ...
Medical Cannabis in the United States: Comparing 2017 and 2024 State Qualifying Conditions to the 2017 National Academies of Sciences Report [0.03%]
美国的医疗大麻：比较2017年和2024年的州资格条件与2017年国家科学院报告
Elena L Stains,Amy L Kennalley,Maria Tian et al.
Elena L Stains et al.
Objective: To compare the 2017 National Academies of Sciences, Engineering, and Medicine cannabis report to state medical cannabis (MC) laws defining approved qualifying conditions (QC) from 2017 and 2024 and to determine...
Medication and Therapy Profiles for Pain and Symptom Management Among Adults With Cerebral Palsy [0.03%]
cerebral palsy成人疼痛和症状管理的药物和治疗概况
Mark D Peterson,Michael O&#x;Leary,Kathryn Ashbaugh et al.
Mark D Peterson et al.
Objective: To examine the most common patterns of pain and symptom management strategies among adults living with cerebral palsy (CP), and to determine if there are differences by pain phenotype or co-occurring neurodevel...
Development of a New Instrument to Measure Workplace Mental Health and Well-Being [0.03%]
开发一种新的工作场所心理健康和幸福感测量工具
Neil J MacKinnon,Preshit N Ambade,Zach T Hoffman et al.
Neil J MacKinnon et al.
Objective: To develop and pilot test a new instrument measuring workplace mental health and well-being among health professionals. Participants and method...
Rethinking Risk in Hypertrophic Cardiomyopathy: Assessing the Role of Myocardial Fibrosis and Left Ventricular Hypertrophy in Sudden Cardiac Death [0.03%]
肥厚型心肌病的风险新思考：评估心肌纤维化和左心室肥厚在心脏性猝死中的作用
Amro Badr,Juan Farina,Reza Arsanjani et al.
Amro Badr et al.
The American College of Cardiology/American Heart Association guidelines recommend implantable cardioverter-defibrillator (ICD) implantation for patients with hypertrophic cardiomyopathy (HCM) with a wall thickness of ≥30 mm (class IIA), w...